In Appeal To Federal Circuit, Makers Of Colitis Drug Dispute Claim Construction
WASHINGTON, D.C. — A Delaware federal judge took a “shortcut” when construing various disputed claim terms in a patent used in the ulcerative colitis drug “Uceris” and other systems for delivering...To view the full article, register now.
Already a subscriber? Click here to view full article